M-Quetiapine Fumarate XR 300 mg

M-Quetiapine Fumarate XR 300 MG is an extended-release tablet used for managing certain mental health conditions. This medication, containing quetiapine fumarate, is designed for oral administration and is manufactured by Mantra Pharma Inc. in Canada.

M-Quetiapine Fumarate XR 300 MG is primarily used for the treatment of schizophrenia and bipolar disorder. This extended-release formulation is designed to provide a steady release of the active ingredient, quetiapine fumarate, over an extended period. Quetiapine is often prescribed to help manage symptoms associated with these conditions, such as hallucinations, delusions, and mood swings. It is important to consult a healthcare provider to determine if this medication is suitable for your specific needs.

Common effects of M-Quetiapine Fumarate XR 300 MG may include drowsiness, dizziness, and dry mouth. Some individuals may also experience weight gain, constipation, or blurred vision. These effects can vary from person to person, and not everyone will experience them. If you have concerns about any side effects, it is advisable to discuss them with a healthcare professional.

When handling M-Quetiapine Fumarate XR 300 MG, it is important to follow the instructions provided by your healthcare provider. This medication should be stored at room temperature, away from moisture and heat. It is crucial to take the tablet whole, without crushing or chewing, to ensure the extended-release mechanism works properly. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

M-Quetiapine Fumarate XR 300 MG may interact with certain medications, including those that affect the central nervous system, such as antidepressants, antipsychotics, and sedatives. Alcohol and other substances that cause drowsiness should be avoided while taking this medication, as they can enhance the sedative effects. It is also important to be cautious when taking medications that affect liver enzymes, as they can alter the metabolism of quetiapine fumarate.